Perception of artificial intelligence and machine learning applications in the Nigerian healthcare sector: A cross-sectional study
Open Access
- 28 May 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 6 (5) , e0006124
Abstract
Artificial intelligence (AI) has significant benefits across various facets of healthcare delivery, notably in personalised pharmacotherapy and the development of targeted health interventions for specific demographic groups. This study aimed to comprehensively evaluate the applications of AI and machine learning (ML) from the perspectives of healthcare professionals in Nigeria . A cross-sectional study design was adopted, and responses were obtained from healthcare professionals across the six geopolitical zones in Nigeria. Data were collected with the aid of a well-structured questionnaire, and a stratified multistage sampling method was employed. Statistical Package for Social Sciences (SPSS) software version 25 was used to analyse the data generated. The results of descriptive analysis and inferential analysis were generated and discussed appropriately. Pharmacists (27.7%), physicians (24.5%), and nurses (19.3%) comprised the largest professional groups, with females representing 55.7% of participants. Most respondents (68.3%) were aged 18–30 years. Two-thirds (67.3%) agreed that ML algorithms can enhance research processes, and a similar proportion (69.5%) believed AI could accelerate drug discovery. Regarding clinical decision-making, 66.6% indicated that AI can support physicians by processing unstructured data, while 77% felt AI and ML could improve pharmaceutical manufacturing. This study revealed positive perceptions from healthcare professionals regarding the applications of AI and ML in the Nigerian health sector. The findings from this study indicate the readiness of the health workforce for a large-scale implementation of AI technologies in the sector.Keywords
This publication has 51 references indexed in Scilit:
- Artificial intelligence in clinical trials: A comprehensive review of opportunities, challenges, and future directionsInternational Journal of Medical Informatics, 2025
- Machine learning models for predicting the activity of AChE and BACE1 dual inhibitors for the treatment of Alzheimer’s diseaseMolecular Diversity, 2021
- Machine learning and deep learningElectronic Markets, 2021
- Novel framework based on deep learning and cloud analytics for smart patient monitoring and recommendation (SPMR)Journal of Ambient Intelligence and Humanized Computing, 2021
- Artificial intelligence in drug discovery and developmentDrug Discovery Today, 2021
- Robotics, Smart Wearable Technologies, and Autonomous Intelligent Systems for Healthcare During the COVID‐19 Pandemic: An Analysis of the State of the Art and Future VisionAdvanced Intelligent Systems, 2020
- Artificial intelligence: radiologists’ expectations and opinions gleaned from a nationwide online surveyLa radiologia medica, 2020
- A Deep Learning Approach to Antibiotic DiscoveryCell, 2020
- Artificial intelligence and the future of psychiatry: Insights from a global physician surveyArtificial Intelligence in Medicine, 2020
- Global Burden of Disease and the Impact of Mental and Addictive DisordersCurrent Psychiatry Reports, 2019